Monday, August 10, 2015
Patent Punting: How FDA and Antitrust Courts Undermine the Hatch-Waxman Act to Avoid Dealing with Patents
Rebecca S. Eisenberg, University of Michigan Law School and Daniel A. Crane, University of Michigan Law School discuss Patent Punting: How FDA and Antitrust Courts Undermine the Hatch-Waxman Act to Avoid Dealing with Patents. ABSTRACT: Under the Hatch-Waxman Act, patent...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment